Will This Analyst Upgrade Help Idexx Laboratories (IDXX) Stock Today?

NEW YORK (TheStreet) -- Canaccord Genuity upgraded Idexx Laboratories  (IDXX) to "buy," set a $148 price target and increased its estimates. The firm noted Catalyst One should help drive growth.

The stock closed at $132.62 on Monday.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

IDXX Chart

IDXX data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

If you liked this article you might like

Cramer: These Stocks Are on a Mission Right Now

Cramer: These Stocks Are on a Mission Right Now

Don't Fall for the Downward Bias: Cramer's 'Mad Money' Recap (Thursday, 2/1/18)

Don't Fall for the Downward Bias: Cramer's 'Mad Money' Recap (Thursday, 2/1/18)

Cramer: What Stocks Are On a Mission Right Now?

Cramer: What Stocks Are On a Mission Right Now?

Meet TheStreet's Pets! They May Be Expensive -- But We Love Them!

Meet TheStreet's Pets! They May Be Expensive -- But We Love Them!

Cramer: Brand Loyalty Between Generations Is Dying

Cramer: Brand Loyalty Between Generations Is Dying